National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Progesterone (micronised) is indicated in women for supplementation of the luteal phase during ART cycles.

 

NCPE Assessment Process Complete
Rapid review commissioned 14/10/2019
Rapid review completed 20/11/2019
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that progesterone (micronised) be considered for reimbursement.*

 

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.